\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={From Acute Pancreatitis to Pancreonekrosis during Pregnancy},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2021 2021-05-15 (revised: 19 Year 2021 15 May 2021)}
\def\TheID{\makeatother }
\def\TheDate{2021 2021-05-15}
\title{From Acute Pancreatitis to Pancreonekrosis during Pregnancy}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{V.?.  Zabolotnov}

             \author[2]{Y.V.  Yakovenko}

             \author[3]{V.Y.  Shatyl?}

             \author[4]{Vira  Yakovenko}

\renewcommand\Authands{ and }

\date{\small \em Received: 9 April 2021 Accepted: 2 May 2021 Published: 15 May 2021}

\maketitle


\begin{abstract}
        


Acute pancreatitis during pregnancy, although a rare but extremely formidable complication, is accompanied by a high level of perinatal and maternal mortality. Excessive hypertriglyceridemia is an extremely important risk factor for pancreatitis, especially during pregnancy. The secretion of cholesterol in hepatic bile increases in the second and reaches a peak in the third trimester compared with bile acids and phospholipids, which leads to a supersaturation of bile. Which determines the highest incidence of acute pancreatitis in pregnant women in the third trimester.The acute onset, the nature of the disease and the difficulties in diagnosis in the treatment of acute pancreatitis in pregnant women significantly threaten the health of the mother and fetus.Although most authors argue that treating acute pancreatitis during pregnancy is similar to treating non-pregnant patients, this is actually far from the truth. During pregnancy, the features of the pathogenesis of acute pancreatitis in pregnant women come to the fore, which must be taken into account when managing these patients.

\end{abstract}


\keywords{pregnancy, acute pancreatitis, pancreatic necrosis, treatment, obstetric tactics.}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{Introduction}]{Introduction}\par
lexander the Great was the Macedonian king from 336 to 323 BC. It was assumed that he could have died from malaria, pneumonia, typhoid fever or West Nile fever, but recently researchers have rejected the old versions of his death. It turned out that the king of Macedonia from the Argead dynasty, the outstanding commander Alexander the Great died as a result of acute pancreatic necrosis -an acute form of pancreatic disease \hyperref[b0]{[1]}. Acute pancreatitis is defined as a sudden inflammation of the pancreas that is clinically present with abdominal pain, nausea and dehydration, which is usually selflimiting, but can sometimes progress to severe illness and even death.\par
While acute pancreatitis accounts for nearly 1 in every 200 hospitalizations in the United States each year, fortunately, the incidence of acute pancreatitis in pregnant women is rare \hyperref[b1]{[2]}.\par
It is estimated that acute pancreatitis occurs in about 1 in every 10,000 pregnancies, but this rate varies by region and type of hospital \hyperref[b1]{[2]}.\par
Acute pancreatitis in pregnant women (APP) most often occurs in the third trimester, and, according to some authors, stones in the gallbladder are the most common cause \hyperref[b2]{[3,}\hyperref[b3]{4]}. This proportion is similar to previously reported studies that also show the majority of cases of stones in gallbladder appealing in the third trimester \hyperref[b3]{[4,}\hyperref[b4]{5]}.\par
In the study, the majority of patients had APP onset during the third trimester (68\%), but 31\% also had APP in the first and second trimesters. This date is similar to previously reported studies \hyperref[b5]{[6,}\hyperref[b6]{7]}.\par
Acute onset, disease progression, difficulties in diagnosis and in treatment of acute pancreatitis in pregnant women significantly threaten the health of the mother and fetus \hyperref[b7]{[8,}\hyperref[b8]{9]}.\par
In previous studies it was shown that the mortality rate was approximately 37\% for a mother and 60\% for a fetus, while, more recent studies show that these numbers have decreased due to improvements in diagnostics, intensive care and newborn care \hyperref[b6]{[7,}\hyperref[b7]{8]}.\par
With regard to diagnosis, treatment, management of pregnancy and timing of delivery, specific guidelines for acute pancreatitis in pregnant women (APP) are still lacking. This is largely due to the low incidence rate and poor clinical data; it is also due to the multidisciplinarity of this condition, when medical care is provided by obstetricians, surgeons, therapists, gastroenterologists, anesthesiologists, etc. \hyperref[b9]{[10]}. 
\section[{Features of etiology and pathogenesis in pregnant women}]{Features of etiology and pathogenesis in pregnant women}\par
There are many causes of acute pancreatitis, but the two most common are:\par
? alcohol consumption, ? disease of the gallbladder / bile ducts \hyperref[b1]{[2]}.\par
It is believed that most cases of APP are caused by gallstone disease. With weight gain and hormonal changes caused by pregnancy, gallstones are more likely to form and thus travel through the common bile duct, obstructing pancreatic drainage.\par
Excessive hypertriglyceridemia (chylomicronemia) is also an extremely important risk factor for pancreatitis, especially during pregnancy. The secretion of cholesterol in hepatic bile increases in the second and reaches a peak in the third trimester compared to bile acids and phospholipids, which leads to bile oversaturation \hyperref[b10]{[11,}\hyperref[b11]{12]}.\par
However, levels achieved are never high enough to cause acute pancreatitis. In patients with familial hypertriglyceridemia, pregnancy can significantly increase hyperlipoproteinemia and may be the cause of acute pancreatitis. Changes in triglyceride clearance of apoprotein or lipoprotein lipase metabolism have been discussed since the 1980s. Timely diagnosis and treatment of familial hypertriglyceridemia can prevent pregnancy complications \hyperref[b12]{[13,}\hyperref[b13]{14]}. Some genetic changes in 30-35\% of cases increase the risk of acute pancreatitis Hormonal changes during pregnancy can predispose to the development of hypertriglyceridemia. When triglyceride levels get too high, oxygen cannot adequately reach the pancreas through the bloodstream and pancreatitis can develop. Of course, during pregnancy, all other causes of acute pancreatitis should be taken into account: alcohol consumption, reactions to certain medications, trauma to the pancreas (Fig. \hyperref[fig_1]{1}). To determine organ failure, three organ systems must first be assessed:\par
This classification \hyperref[b4]{[5]} defines three degrees of severity of the disease course: 
\section[{Mild acute pancreatitis [16]}]{Mild acute pancreatitis [16]}\par
It is characterized by the absence of organ failure and the absence of local or systemic complications. Patients with mild acute pancreatitis. Patients with mild acute pancreatitis usually do not require imaging of the pancreas, are discharged early and mortality is very rare (but possible). 
\section[{Moderate acute pancreatitis [16]}]{Moderate acute pancreatitis [16]}\par
It is characterized by the presence of temporary organ failure, local or systemic complications in the absence of permanent organ failure. An example of a symptomatic local complication is peripancreaticedema resulting in prolonged abdominal pain, leukocytosis, and fever, or which interferes with the ability to maintain oral nutrition.\par
An example of a symptomatic systemic complication is exacerbation of coronary artery disease or chronic lung disease caused by acute pancreatitis.\par
Moderate acute pancreatitis may resolve without intervention (as with temporary organ failure or with the absorption of additional fluid), or long-term specialized care may be required (as with extensive sterile necrosis without organ failure).\par
Mortality in acute pancreatitis of moderate severity with 15-50\% is much less than in acute severe pancreatitis. 
\section[{Severe acute pancreatitis [16]}]{Severe acute pancreatitis [16]}\par
Severe acute pancreatitis is characterized by persistent organ failure. Organ failure, which develops at an early stage, is triggered by the activation of cytokine cascades leading to SIRS -systemic inflammatory response syndrome.\par
When SIRS is present and persistent, there is an increased risk that pancreatitis will be complicated by persistent organ failure and the patient should be treated as if they had severe acute pancreatitis.\par
Persistent organ failure can be single or multiple organ failure.\par
Patients with persistent organ failure usually have one or more local complications.\par
Patients who develop persistent organ failure during the first few days of illness are at increased risk of death, and mortality is > 50\%.\par
The development of infected necrosis in patients with persistent organ failure is associated with extremely high mortality.\par
The severe course of acute pancreatitis \hyperref[b14]{[17]} is characterized by such data as:\par
In addition, the presence of organ failure and/or pancreatic necrosis immediately classifies acute pancreatitis as severe.\par
Systemic complications of acute pancreatitis during pregnancy: ? Respiratory function is impaired due to pleural effusion, atelectasis, acute pulmonary edema, or ARDS, resulting in hypoxemia and dyspnea \hyperref[b15]{[18,}\hyperref[b17]{19]}. ? Circulatory complications are characterized by shock due to hypovolemia and/or hypotension. The main causes are retroperitoneal or peritoneal fluid loss and/or peripheral vasodilation \hyperref[b17]{[19]}. ? Cardiac complications are characterized by tachycardia and nonspecific abnormalities rather than decreased cardiac function due to a young age in a pregnant woman. ? Disorders of coagulation and especially DIC (disseminated intravascular coagulation) are very important during pregnancy, as they are accompanied by multiple organ failure and lead to a high incidence of intrauterine and maternal mortality \hyperref[b17]{[19]}. ? Renal function is impaired during severe acute pancreatitis, resulting in uremia and oliguria, either through prerenal azotemia or acute tubular necrosis \hyperref[b17]{[19,}\hyperref[b18]{20]}. ? Metabolic complications include hypocalcemia, hyperglycemia, hypertriglyceridemia, hypoglycemia, and acid-base disorders \hyperref[b19]{[21]}. APP can be classified for various pathogenic reasons \hyperref[b4]{[5]}.\par
? Acute gallstone pancreatitis is diagnosed by an elevated ALT level> 150 U/l within 48 hours from the onset of the disease, as well as by X-ray data, abdominal ultrasound and magnetic resonance cholangiopancreatography (MRCP) \hyperref[b4]{[5]}. ? Interstitial edematous pancreatitis ? Necrotizing pancreatitis.?\par
? Respiratory,\par
? Cardiovascular ? Renal.\par
? Mild acute pancreatitis,\par
? Moderately acute pancreatitis,\par
? Severe acute pancreatitis.\par
? Signs of hypovolemia (elevated blood urea),\par
? Increased hematocrit,\par
? Increased creatinine,\par
? Clinical signs of pulmonary involvment, such as pleural effusion and/or infiltration, indicate that this patient may have severe acute pancreatitis.\par
diagnosed based on abnormal serum triglyceride levels ? 11.3 mmol/ l or serum triglyceride levels between 5.65 and 11.3 mmol/l. ? Idiopathic pancreatitis is diagnosed by radiological signs of pancreatitis after excluding gallstones, alcohol, hypertriglyceridemia, drug treatment, trauma, autoimmune and surgical factors \hyperref[b4]{[5]}. 
\section[{Main clinical symptoms:}]{Main clinical symptoms:}\par
? Extremely important: acute pain in the upper abdomen, similar to the girdle (+ increased serum pancreatic enzyme). ? Other common symptoms: ? Fever, tachycardia, nausea, vomiting. ? Tension of the abdominal wall ("rubber bellysensations resemble pressing on a slightly deflated rubber ball"), flatulence, paralytic incomplete (partial) intestinal obstruction, Blumberg sign symptom is doubtful or negative. With the development of peritonitis, Blumberg sign becomes positive.\par
One of the studies \hyperref[b4]{[5]} indicated that abdominal pain and vomiting remained the two most predominant clinical symptoms in pregnant women with APP. Abdominal pain was localized mainly in the upper abdomen, which was observed in 86.8\% of patients (105/121), while only 11.6\% had lower (5.0\%, 6/121) or generalized pain in abdomen (6.6\%, 8/121). More than half of the patients had vomiting (73.6\%, 89/121) and fever was less common (23.1\%, 28/121). The tension of the muscles of the anterior abdominal wall was mainly in the upper abdomen (91\%, 90/99), while only 3\% was in the lower abdomen (3/99) and 6\% of the entire anterior abdominal wall (6/99) \hyperref[b4]{[5]}.\par
Depending on the severity of the APP and the cause, the following complications may be present:\par
? Circulatory reaction: hypotension, shock, ? Ascites, pleural effusions (left> right),\par
? Jaundice (often only shortly) in the presence of common bile duct stones, ? Rare, but prognostically unfavorable signs: cyanosis of the skin around the navel -with hemorrhage into the abdominal cavity (Cullen sign) or hemorrhagic cyanotic spots on the left lateral wall of the abdomen, sometimes with a yellowish tinge (Gray-Turner sign) ? Scoring systems for determining severity, such as the Ranson Criteria (clinical prediction rules for predicting the disease and mortality risks of acute pancreatitis) are of secondary importance in practice.\par
Important criteria that indicate a severe course are: clinical symptoms (pain, shock symptoms), CRP increase (>120 mg/l), creatinine increase (>1.2 mg/dl) and decrease in pO2. 
\section[{Complications of APP:}]{Complications of APP:}\par
? Shock due to lack of circulating blood volume, release of vasodilators and toxic substances. Consequences: acute renal failure, pulmonary shock (ARDS), consumption coagulopathy.   
\section[{Laboratory deviations and severity of APP}]{Laboratory deviations and severity of APP}\par
Increased serum lipase and pancreatic amylase. Sensitivity of lipase> amylase; absolute values do not correlate with the severity of the disease (it is not always a reliable "marker" for controlling the course of the disease). 
\section[{Depending on the cause and course:}]{Depending on the cause and course:}\par
? leukocytosis(leukocyte count> 10 × 109 /l) ? increase in CRP and LDH, CRP = marker of severity! ? by cholestasis an increase in AP, ?GT, as well as "direct" bilirubin ? by diabetes mellitus hyperglycemia(fasting glucose ? 7.8mmol/l) ? hypocalcemia(serum calcium <1.75mmol/l) ? an increase in urea and creatinine.\par
Hypertriglyceridemiais defined as fasting serumtriglyceride level ?11.3mmol/l. 
\section[{Signs of systemic inflammatory response syndrome (SIRS)}]{Signs of systemic inflammatory response syndrome (SIRS)}\par
SIRS -determined by the presence of two or more criteria: 1. Heart rate> 90 /min 2. Body temperature <36 °C or >38 °C 3. The level of leukocytes in the blood <4000 or >12000 /mm 3 4. Breathing rate >20/min or pCO2 art. <33 mmHg.\par
According to one of the studies \hyperref[b4]{[5]}, only serum calcium level correlated negatively with the severity of APP (p <0.01), which corresponds to date from nonpregnant patients with pancreatitis. Serum glucose, triglycerides, or leukocyte levels did not correlate with the severity of APP. Some of the most commonly used laboratory results were compared based on the severity of APP (Table \hyperref[tab_1]{1}). Testing serum calcium may indicate( D D D D )\par
K the severity of the disease, but more investigation is needed to confirm this \hyperref[b4]{[5]}.  
\section[{Therapy}]{Therapy}\par
Although most authors claim that the treatment of acute pancreatitis during pregnancy is similar to that in non-pregnant patients, this is actually should be taken with caution. During pregnancy, the features of the pathogenesis of APP must be taken into account when managing these patients. The medical stuff (primarily obstetricians) are faced with the question of the feasibility of maintaining the pregnancy, the fetus, the timing and method of termination of pregnancy, and today these are extremely controversial decisions. And it is no coincidence that in the scientific obstetric literature there are many articles on surgical tactics, but not on the obstetric-surgical management of patients with APP.\par
When assessing pregnant women with acute pancreatitis, it is proposed to answer four important questions, namely: 
\section[{1) Does this patient have acute pancreatitis (diagnosis and exclusion of other causes)?}]{1) Does this patient have acute pancreatitis (diagnosis and exclusion of other causes)?}\par
2) If it is acute pancreatitis, what is the predicted severity (mild or severe?) 3) Is there a biliary pathology? 4) 1st, 2nd or 3rdtrimester of pregnancy? This last question will determine the choice of imaging and therapy regimen \hyperref[b21]{[23]}. 
\section[{Conservative therapy}]{Conservative therapy}\par
It is very important that if a pregnant woman develops any abnormal abdominal pain symptoms, she should be admitted to the emergency department as soon as possible to assess her condition. Initial treatment is aimed to reduce exocrine pancreatic secretion, restoring third-space fluid sequestration, and supporting the patient by providing adequate nutrition, oxygenation, analgesics, and monitoring of maternal and fetal vital functions \hyperref[b22]{[24]}.\par
Initial treatment for acute pancreatitis is limited to forced intravenous hydration of 250-500 ml/h of isotonic crystalloid solution, preferably lactated Ringer's solution, unless cardiovascular, renal, or other comorbilities are present \hyperref[b23]{[25]}. The forces intravenous hydration is indicated within the first 12 to 24 hours.\par
In patients with circulatory manifestations of severe fluid loss such as hypotension and tachycardia, more aggressive hydration is recommended. Fluid requirements should be reviewed at frequent intervals over the next 48 hours by assessing blood urea levels \hyperref[b25]{[26]}.\par
According to SNAP-Based Recommendations (Multicenter Nutritional Study in Acute Pancreatitis was conducted in the US by the National Institutes of Health) \hyperref[b26]{[27]}: 
\section[{Patients with symptoms of ileus should be fed parenterally !!!!}]{Patients with symptoms of ileus should be fed parenterally !!!!}\par
? Nutrition improves intestinal integrity, reduces the movement of bacteria and therefore the rate of serious infections. ? Start early with a jejunaltube feeding.\par
? It is recommended to combine the use of enteral and parenteral nutrition, especially in the case of severe forms, since exclusively enteral nutrition cannot adequately cover the patient's energy/fluid/electrolyte costs.\par
? Parenteral fluid and electrolyte supply should be controlled by electrolyte balance and CVP (CVP target 4-12 cm H2O). Ultrasound control of the inferior vena cava: hypovolemie by diameter <1.8cm (norm 1.8-2 cm). Fluid requirements 2-4 l/day for mild pancreatitis, up to 10 l/day for severe pancreatitis \hyperref[b27]{[28]}. For high fluid requirements (>4 l/day) replacement of human albumin should not be forgotten: for example, 500ml of 5\% human albumin per 4l of fluid (serum albumin control). ? Caution: depending on the severity of the condition, CVP may be overestimated due to increased intraabdominal pressure, resulting elevated diaphragm, so volume requirements may be underestimated. ? Pain manegment (regular administration, dosage based on need): ? Pethidine: s/c or i/v as an injection or in a perfuser.\par
Single dose 50-100 mg, max.every 2-3 hours, max. 500 mg/day ? Pyritramide/Dipidolor: s/c or intravenously as an injection or in a perfuser. Single dose 15-30 mg, max.every 4 -6 hours, max. 300 mg/day ? Epidural catheter, eg with bupivacaine (eg Carbostesin® 0.25\%, 5-10 mg/h = 2-4 ml/h), with a high infusion level (Th 7-10), and good prevention of ileus. 
\section[{Advanced therapy:}]{Advanced therapy:}\par
? For biliary pancreatitis -ERCP and possibly simultaneous papillotomy with stone removal. not help and there is an unresolved septic focus (high mortality). ? Enteral feeding: start as early as possible in a painfree period, low-fat food, possibly additional enzyme preparations.\par
? Prevention of relapse: for example, debridement of the bile ducts for calculus, abstinence from alcohol, treatment of hypertriglyceridemia or hyperparathyroidism. Some recent reports \hyperref[b29]{[30]} suggested a combination of intravenous infusion of heparin and insulin in severe cases of gestational hypertriglyceridemia caused by acute pancreatitis, which increased lipoprotein lipase activity.\par
In addition, although there is no clear clinical guideline, the use of plasmapheresis and hemofiltration may also be beneficial in some cases \hyperref[b30]{[31]}. 
\section[{Surgical treatment}]{Surgical treatment}\par
As for the disease itself, surgical treatment is suggested in special cases of necrotizing pancreatitis. Sterile necrosis, as well as asymptomatic local changes such as a pancreatic pseudocyst, do not require intervention regardless of size, location and/or expansion \hyperref[b31]{[32,}\hyperref[b32]{33]}.\par
In case of progression of a pseudocyst (> 6 cm) or complications (infection, compression of adjacent structures), an internal drainage and/or removal of the cyst is surgically performed \hyperref[b2]{[3]}.\par
Surgical treatment: only if conservative therapy does not help and there is a non-sanitized septic focus (high mortality). 
\section[{Interventional treatment of APP}]{Interventional treatment of APP}\par
Usually, if gallstones result pancreatitis, the removal of the gallbladder is delayed until the end of the pregnancy. Often, a stent placed in the bile duct can correct the situation until operative resection is required \hyperref[b31]{[32]}. However, if waiting until the end of pregnancy is not possible, surgical resection can usually be performed safely, especially before 28-30 weeks of gestation \hyperref[b33]{[34]}.\par
In stable patients with infected necrosis, surgery should be delayed for more than 4 weeks from the onset of symptoms so that the lesions can be organized into a more specific shape \hyperref[b25]{[26]}.\par
Treatment of stones in the biliary tract can be Xray surgical-antegradetranshepatic access to the ducts (limited during pregnancy), as well as endoscopic retrograde access through an endoscope in duodenum. Both of these approaches can mechanically destroy the stones, then they will independently enter the intestinal lumen, or remove them. Bile duct stenting is not required in this situation.\par
Acute biliary pancreatitis in pregnant women requires surgical treatment only when there is: However, in necrotizing acute biliary pancreatitis, cholecystectomy must wait until active inflammation subsides, fluid accumulations dissolve and stabilize in order to avoid contamination of necrotic tissue regardless of the severity of the disease \hyperref[b21]{[23]}. 
\section[{Obstetric procedure}]{Obstetric procedure}\par
The data in Tables 2-4 provide strong evidence of the relationship between the severity of APP, hyperlipidemia, and maternal and fetal outcome \hyperref[b34]{[35,}\hyperref[b35]{36]}.\par
Hyperlipidemia (hypertriglyceredemia) is an extremely dangerous symptom and is mainly combined with moderate severity and severe course of APP, leading to fetal distress and fetal loss \hyperref[b36]{[37,}\hyperref[b37]{38]}.  The severe course of APP is extremely dangerous for the fetus and leads in all cases to its distress and in 60.0\% of cases to fetal loss (Table \hyperref[tab_5]{4}). The moderate severity of pancreatitis is also unfavorable for the fetus and is accompanied by its loss in every fourth case (25\%) \hyperref[b25]{[26]}.\par
If fetal distress occurs in the period of gestation from 22 to 26 weeks and there are no conditions for high professional resuscitation of the newborn (a favorable perinatal outcome is extremely doubtful), the decision on the strategy of pregnancy management and/or its termination, first of all, is made in favor of saving the health and life of the pregnant woman. If triglycerides are the cause of acute pancreatitis, urgent termination of pregnancy is indicated. Before 30 weeks of gestation, and in the presence of professional newborn resuscitation, urgent delivery is preferred, as this will lead to an immediate decrease in triglyceride levels \hyperref[b38]{[39,}\hyperref[b40]{40]}.\par
When the cervix is ready for childbirth, it is advisable to deliver through the natural birth canal. During childbirth after 28 weeks (approximately at this time), monitoring of the intrauterine state of the fetus is indicated.\par
At the same time, the outcome of delivery largely depends on the severity of acute pancreatitis (Table \hyperref[tab_6]{5}), and does not always depend on the method of delivery. A cesarean section performed in conjunction with a surgeon allows immediate delivery of a pregnant woman with APP, increases the likelihood of a favorable perinatal outcome, creates conditions for performing the necessary amount of surgical interventions for pancreatitis, but increases the risk of septic complications. Delivery through the natural birth canal reduces the risk of purulent-septic complications, but somewhat delays the time of delivery. Therefore, the decision on the method of delivery is made by the council after considering all risk factors. During a cesarean section, the decision whether the surgical intervention due to pancreatitis should be extended or not should meet a surgeon (preferably a council of surgeons). 
\section[{Indications for immediate pregnancy termination:}]{Indications for immediate pregnancy termination:}\par
1. Moderate and severe acute pancreatitis; 2. Pancreatic necrosis (or reasonable suspicion of it); 3. The presence of organ failure -acute renal failure, ARDS 4. Hypertriglyceridemia; 5. Hypocalcemia; 6. Complications of pancreatitis: shock, consumption coagulopathy, abscess, sepsis, extensive necrosis and hemorrhage, paralytic ileus.\par
II. 
\section[{Conclusion}]{Conclusion}\par
The management of pregnant women with acute pancreatitis is an extremely difficult task, despite the achievements of recent years, and is accompanied by high perinatal and maternal mortality, the level of which depends, first of all, on the severity of acute pancreatitis.\par
The management of such pregnant women with acute pancreatitis requires a multidisciplinary approach to predict the course of pancreatitis, to determine the\begin{figure}[htbp]
\noindent\textbf{}\includegraphics[]{image-2.png}
\caption{\label{fig_0}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{1}\includegraphics[]{image-3.png}
\caption{\label{fig_1}Figure 1 :}\end{figure}
   \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.22543142597638507\textwidth}P{0.02084468664850136\textwidth}P{0.4987284287011807\textwidth}P{0.05249772933696639\textwidth}P{0.031653042688465034\textwidth}P{0.02084468664850136\textwidth}}
\tabcellsep \tabcellsep Mild\tabcellsep Moderate\tabcellsep Severe\tabcellsep P value\\
Number of cases\tabcellsep \tabcellsep 59\tabcellsep 44\tabcellsep 18\\
Hyperglycemia\tabcellsep \multicolumn{2}{l}{10 (16.9)}\tabcellsep 13 (29.5)\tabcellsep 7 (38.9)\tabcellsep 0.111\\
Hypertriglyceredemia\tabcellsep \multicolumn{2}{l}{10 (16.9)}\tabcellsep 13 (29.5)\tabcellsep 7 (38.9)\tabcellsep 0.185\\
Hypocalcemia\tabcellsep \tabcellsep 3 (5.1)\tabcellsep 7 (15.9)\tabcellsep 8 (44.4)\tabcellsep <0.01\\
Increased white blood cell count\tabcellsep \multicolumn{2}{l}{45 (76.3)}\tabcellsep 36 (81.8)\tabcellsep 15 (83.3)\tabcellsep 0.712\\
\multicolumn{5}{l}{Program of acute pancreatitis monitoring J.M. Hahn, G.Adler 2012 [22]}\\
Monitoring interval\tabcellsep \tabcellsep \tabcellsep \multicolumn{2}{l}{Criteria for evaluation}\\
Several times a day\tabcellsep \tabcellsep \multicolumn{4}{l}{Health condition (degree of abdominal pain), palpation and auscultation}\\
\tabcellsep \tabcellsep \multicolumn{4}{l}{of the abdomen, blood pressure, pulse, fluid balance, CVP/ultrasound}\\
\tabcellsep \tabcellsep \multicolumn{3}{l}{control of the inferior vena cava, body temperature}\\
\multicolumn{2}{l}{At least daily (depending on individual}\tabcellsep \multicolumn{2}{l}{Laboratory parameters:}\tabcellsep \\
parameters also more often)\tabcellsep \tabcellsep \multicolumn{2}{l}{? Blood count}\tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{3}{l}{? Creatinine, Na +, K +, Ca ++}\\
\tabcellsep \tabcellsep \multicolumn{2}{l}{? AP , ?GT, AST}\tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{2}{l}{? Bilirubin}\tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{3}{l}{? Coagulation parameters Quick/INR, PTT)}\\
\tabcellsep \tabcellsep \multicolumn{2}{l}{? CRP and LDH}\tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{2}{l}{? protein/albumin}\tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{2}{l}{? daily sugar profile}\tabcellsep \\
\tabcellsep \tabcellsep ? BGA\tabcellsep \tabcellsep \\
\tabcellsep \tabcellsep \multicolumn{2}{l}{Abdominal sonography}\tabcellsep \\
With clinical deterioration\tabcellsep \tabcellsep \multicolumn{4}{l}{Rö-Ð?"?????? ??????/??????? ???????, ??Ð?" ??????????}\\
\tabcellsep \tabcellsep \multicolumn{3}{l}{Ð?"????????????: ??/??? ??? ????-???}\\
\tabcellsep \tabcellsep \multicolumn{3}{l}{???????? ????Ð?", ????????????? ??????????}\\
\tabcellsep \tabcellsep \multicolumn{3}{l}{Rö Thorax/Abdominal, ECG Monitoring}\\
\tabcellsep \tabcellsep \multicolumn{3}{l}{Optional: CT/MRI or endo-ultrasound}\\
\tabcellsep \tabcellsep \multicolumn{2}{l}{possibly ERCP, surgical observation}\tabcellsep \end{longtable} \par
 
\caption{\label{tab_1}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2} \par 
\begin{longtable}{P{0.15210526315789474\textwidth}P{0.1744736842105263\textwidth}P{0.1968421052631579\textwidth}P{0.09394736842105263\textwidth}P{0.23263157894736844\textwidth}}
Etiology\tabcellsep Mild N=23\tabcellsep Moderate N=24\tabcellsep Severe N=7\tabcellsep Number of Pat. N=54\\
Biliary\tabcellsep 9 (39.1\%)\tabcellsep 5 (20.8\%)\tabcellsep 0\tabcellsep 14 (25.9\%)\\
Hyperlipidemia\tabcellsep 1 (4.2\%)\tabcellsep 14 (58.4\%)\tabcellsep 7 (100\%)\tabcellsep 22 (40.7\%)\\
Other\tabcellsep 13 (56.6\%)\tabcellsep 5 (20.8\%)\tabcellsep 0\tabcellsep 18 (33.4\%)\end{longtable} \par
 
\caption{\label{tab_3}Table 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3} \par 
\begin{longtable}{P{0.22666666666666666\textwidth}P{0.14166666666666666\textwidth}P{0.2172222222222222\textwidth}P{0.12277777777777776\textwidth}P{0.14166666666666666\textwidth}}
\tabcellsep Biliary\tabcellsep Hyperlipidemia\tabcellsep Other\tabcellsep \\
\tabcellsep (n=14)\tabcellsep (n=22)\tabcellsep (n=18)\tabcellsep P value\\
fetal distress\tabcellsep 2\tabcellsep 14\tabcellsep 4\tabcellsep <.01\\
fetal loss\tabcellsep 1\tabcellsep 7\tabcellsep 3\tabcellsep .203\end{longtable} \par
 
\caption{\label{tab_4}Table 3 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{4} \par 
\begin{longtable}{P{0.29917184265010355\textwidth}P{0.11262939958592133\textwidth}P{0.13022774327122152\textwidth}P{0.11614906832298137\textwidth}P{0.13022774327122152\textwidth}P{0.06159420289855073\textwidth}}
\tabcellsep Mild\tabcellsep Moderate\tabcellsep Severe\tabcellsep Number\tabcellsep \\
\tabcellsep N=23\tabcellsep N=24\tabcellsep N=7\tabcellsep N=54\tabcellsep P value\\
Spontaneous delivery on term\tabcellsep 20 (87.0\%)\tabcellsep 11 (45.8\%)\tabcellsep 0 (0.0\%)\tabcellsep 31 (57.4\%)\tabcellsep <.001\\
Pregnancy termination due to maternal and/or fetal\tabcellsep 2 (8.7\%)\tabcellsep 3 (12.5\%)\tabcellsep 0 (0.0\%)\tabcellsep 5 (9.26\%)\tabcellsep >.999\\
complications\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
Premature birth\tabcellsep 0 (0.0\%)\tabcellsep 7 (29.2\%)\tabcellsep 5 (71.4\%)\tabcellsep 12 (22.2\%)\tabcellsep <.001\\
Abortion (spontaneous or med. indicated)\tabcellsep 1 (4.3\%)\tabcellsep 3 (12.5\%)\tabcellsep 2 (26.6\%)\tabcellsep 6 (11.1\%)\tabcellsep .211\\
Fetal distress\tabcellsep 2 (8.7\%)\tabcellsep 11 (45.8\%)\tabcellsep 7 (100\%)\tabcellsep 20 (37.0\%)\tabcellsep <.001\\
Fetal loss\tabcellsep 1 (4.3\%)\tabcellsep 6 (25.0\%)\tabcellsep 4 (57.1\%)\tabcellsep 11 (20.4\%)\tabcellsep .007\end{longtable} \par
 
\caption{\label{tab_5}Table 4 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{5} \par 
\begin{longtable}{P{0.23448275862068965\textwidth}P{0.35172413793103446\textwidth}P{0.2637931034482759\textwidth}}
Mild\tabcellsep Moderate\tabcellsep Severe\\
N=23\tabcellsep N=24\tabcellsep N=7\end{longtable} \par
 
\caption{\label{tab_6}Table 5 :}\end{figure}
 			\footnote{© 2021 Global JournalsFrom Acute Pancreatitis to Pancreonekrosis during Pregnancy} 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Gardner]{b1}\label{b1} 	 		\textit{},  		 			Timothy Gardner 		.  		 \url{https://pancreasfoundation.org/patient-information/acute-pancreatitis/pancreatits-and-pregnancy/}  		 	 
\bibitem[]{b16}\label{b16} 	 		\textit{},  		 \xref{http://dx.doi.org/10.4103/2229-516X.117090}{10.4103/2229-516X.117090}.  		 \url{http://dx.doi.org/10.4103/2229-516X.117090}  		 	 
\bibitem[Hahn et al.]{b20}\label{b20} 	 		\textit{},  		 			J M Hahn 		,  		 			MD 		,  		 			G Adler 		,  		 			Prof 		.  		 MD 2012.  	 	 		\textit{Innere Medizin)}  		 	 
\bibitem[ American Journal of Gastroenterology]{b24}\label{b24} 	 		\textit{},  		 \xref{http://dx.doi.org/10.1038/ajg.2013.218}{10.1038/ajg.2013.218}.  		 \url{http://dx.doi.org/10.1038/ajg.2013.218}  	 	 		\textit{American Journal of Gastroenterology}  		108 p. .  	 
\bibitem[Jeon et al.]{b38}\label{b38} 	 		\textit{},  		 			H R Jeon 		,  		 			S Y Kim 		,  		 			Y J Cho 		.  		 	 
\bibitem[Montgomery and Miller ()]{b6}\label{b6} 	 		\textit{},  		 			W H Montgomery 		,  		 			F C Miller 		.  	 	 		\textit{Pancreatitis and pregnancy. ObstetGynecol}  		1970. 35  (4)  p. .  	 
\bibitem[Eddy et al. ()]{b11}\label{b11} 	 		\textit{},  		 			J J Eddy 		,  		 			M D Gideonsen 		,  		 			J Y Song 		,  		 			W A Grobman 		,  		 			O 'halloran 		,  		 			P 		.  		 doi: 10.1097/ AOG.0b013e318185a032.  	 	 		\textit{Pancreatitis in pregnancy. ObstetGynecol}  		2008. 112  (5)  p. .  	 
\bibitem[Villatoro ()]{b28}\label{b28} 	 		\textit{},  		 			E Villatoro 		.  	 	 		\textit{Cochrane Database Syst. Rev}  		2010, 5, CD002941 17054156.  	 
\bibitem[Ntzeros ()]{b14}\label{b14} 	 		\textit{},  		 			K Ntzeros 		.  	 	 		\textit{Open Journal of Obstetrics and Gynecology}  		2014. 4 p. .  	 
\bibitem[Tang ()]{b25}\label{b25} 	 		\textit{},  		 			Tang 		.  	 	 		\textit{Medicine}  		2018. 97 p. 7.  	 
\bibitem[Date and Kaushal ()]{b5}\label{b5} 	 		‘A review of the management of gallstone disease and its complications in pregnancy’.  		 			R S Date 		,  		 			M Kaushal 		,  		 			RameshA 		.  		 \xref{http://dx.doi.org/10.1016/j.amjsurg.2008.01.015}{10.1016/j.amjsurg.2008.01.015}.  		 S0002- 9610(08)00308-5.  	 	 		\textit{Am J Surg}  		2008. 196  (4)  p. .  	 
\bibitem[Kim et al. ()]{b9}\label{b9} 	 		‘Acute idiopathic pancreatitis in pregnancy: a case study’.  		 			J Y Kim 		,  		 			S H Jung 		,  		 			H W Choi 		.  	 	 		\textit{World J Gastroenterol}  		2014. 20 p. .  	 
\bibitem[Tang et al. ()]{b17}\label{b17} 	 		‘Acute pancreatitis during pregnancy’.  		 			S J Tang 		,  		 			E Rodriguez-Frias 		,  		 			S Singh 		,  		 			M J Mayo 		,  		 			S F Jazrawi 		,  		 			J Sreenarasimhaiah 		,  		 			L F Lara 		,  		 			D C Rockey 		.  	 	 		\textit{Clinical Gastroenterology and Hepatology}  		2010. 8 p. .  	 
\bibitem[Altraigey and Asiri ()]{b31}\label{b31} 	 		‘Acute Pancreatitis during Pregnancy: A Case Report’.  		 			A Altraigey 		,  		 			M Asiri 		.  	 	 		\textit{Austin J Obstet Gynecol}  		2018. 5  (7)  p. 1120.  	 
\bibitem[Ducarme et al. ()]{b10}\label{b10} 	 		‘Acute pancreatitis during pregnancy: a review’.  		 			G Ducarme 		,  		 			F Maire 		,  		 			P Chatel 		,  		 			D Luton 		,  		 			P Hammel 		.  		 \xref{http://dx.doi.org/10.1038/jp.2013.161}{10.1038/jp.2013.161}.  	 	 		\textit{J Perinatol}  		2014. 34  (2)  p. .  	 
\bibitem[Sun et al. ()]{b12}\label{b12} 	 		‘Acute pancreatitis in pregnancy’.  		 			L Sun 		,  		 			W Li 		,  		 			Y Geng 		,  		 			B Shen 		,  		 			J Li 		.  		 \xref{http://dx.doi.org/10.1111/j.1600-0412.2011.01072.x}{10.1111/j.1600-0412.2011.01072.x}.  	 	 		\textit{ActaObstet GynecolScand}  		2011. 90  (6)  p. .  	 
\bibitem[Li et al. ()]{b19}\label{b19} 	 		‘Acute pancreatitis in pregnancy: A 6-year single center clinical experience’.  		 			H P Li 		,  		 			Y J Huang 		,  		 			X Chen 		.  	 	 		\textit{Chinese Medical Journal}  		2011. 124 p. .  	 
\bibitem[Juneja et al. ()]{b15}\label{b15} 	 		‘Acute pancreatitis in pregnancy: A treatment paradigm based on our hospital experience’.  		 			S K Juneja 		,  		 			S Gupta 		,  		 			S S Virk 		,  		 			P Tandon 		,  		 			V Bindal 		.  	 	 		\textit{International Journal of Applied and Basic Medical Research}  		2013. 3 p. .  	 
\bibitem[Papadakis et al. ()]{b8}\label{b8} 	 		‘Acute pancreatitis in pregnancy: an overview’.  		 			E P Papadakis 		,  		 			M Sarigianni 		,  		 			D P Mikhailidis 		,  		 			A Mamopoulos 		,  		 			V Karagiannis 		.  	 	 		\textit{Eur J ObstetGynecolReprodBiol}  		2011. 159  (2)  p. .  	 
\bibitem[Tenner et al. ()]{b23}\label{b23} 	 		\textit{American College of Gastroenterology guideline: Management of acute pancreatitis},  		 			S Tenner 		,  		 			J Baillie 		,  		 			J Dewitt 		,  		 			S S Vege 		.  		2013.  	 
\bibitem[Altun et al. ()]{b29}\label{b29} 	 		‘An alternative treatment in hypertriglyceridemia-induced acute pancreatitis in pregnancy: plasmapheresis’.  		 			D Altun 		,  		 			G Eren 		,  		 			Z Cukurova 		.  	 	 		\textit{J AnaesthesiolClinPharmacol}  		2012. 28 p. .  	 
\bibitem[Jain et al. ()]{b22}\label{b22} 	 		‘Biliary pancreatitis in pregnancy’.  		 			V Jain 		,  		 			B Yegneswaran 		,  		 			C S Pitchumoni 		.  	 	 		\textit{Practical Gastroenterology}  		2009. 33 p. .  	 
\bibitem[Huang et al. ()]{b30}\label{b30} 	 		‘Clinical features and treatment of hypertriglyceridemia-induced acute pancreatitis during pregnancy: a retrospective study’.  		 			C Huang 		,  		 			J Liu 		,  		 			Y Lu 		.  	 	 		\textit{J ClinApher}  		2016. 31 p. .  	 
\bibitem[Qihui et al. ()]{b18}\label{b18} 	 		‘Clinical study on acute pancreatitis in pregnancy in 26 cases’.  		 			C Qihui 		,  		 			Z Xiping 		,  		 			D Xianfeng 		.  		 \xref{http://dx.doi.org/10.1155/2012/271925}{10.1155/2012/271925}.  		 \url{http://downloads.hindawi.com/journals/grp/2012/271925.pdfhttp://dx.doi.org/10.1155/2012/271925}  	 	 		\textit{Gastroenterology Research and Practice}  		2012. 2012. p. 271925.  	 
\bibitem[Hasanpour et al. ()]{b37}\label{b37} 	 		‘Evaluation of the effects of acoustic stimulation and feeding mother stimulation on non-reactive nonstress test: a randomized clinical trial’.  		 			S Hasanpour 		,  		 			S Raouf 		,  		 			N Shamsalizadeh 		.  	 	 		\textit{Arch GynecolObstet}  		2013. 287 p. .  	 
\bibitem[Suatzenginbehcet Al Sinan ()]{b27}\label{b27} 	 		‘GencSüleymanErcan Mehmet DoganGokhanAltunbas Role of inferior vena cava and right ventricular diameter in assessment of volume status: a comparative study’.  		 			Suatzenginbehcet Al Sinan 		.  	 	 		\textit{The American Journal of Emergency Medicine}  		MAY 01. 2013. 31  (5)  p. .  	 
\bibitem[Mali (2016)]{b2}\label{b2} 	 		\textit{Hepatobiliary Pancreat Dis Int},  		 			P Mali 		.  		2016 Aug. 15 p. .  	 
\bibitem[Hypertriglyceridemia-induced acute pancreatitis in pregnancy causing maternal death Obstet GynecolSci ()]{b39}\label{b39} 	 		‘Hypertriglyceridemia-induced acute pancreatitis in pregnancy causing maternal death’.  	 	 		\textit{Obstet GynecolSci}  		2016. 59 p. .  	 
\bibitem[Hsieh et al. ()]{b26}\label{b26} 	 		‘Infection rate among nutritional therapies for acute pancreatitis: A systematic review with network meta-analysis of randomized controlled trials’.  		 			P-H Hsieh 		,  		 			H-Y Su 		,  		 			C-Y Lin 		,  		 			Y-N Kang 		,  		 			C-C Chang 		.  		 \xref{http://dx.doi.org/10.1371/journal.pone.0219151}{10.1371/journal.pone.0219151}.  		 \url{https://doi.org/10.1371/journal.pone.0219151}  	 	 		\textit{PLoS ONE}  		2019. 14  (7)  p. e0219151.  	 
\bibitem[Sun et al. ()]{b3}\label{b3} 	 		‘Intra-abdominal pressure in third trimester pregnancy complicated by acute pancreatitis: an observational study’.  		 			L Sun 		,  		 			W Li 		,  		 			F Sun 		,  		 			Y Geng 		,  		 			Z Tong 		,  		 			J Li 		.  	 	 		\textit{BMC Pregnancy Childbirth}  		2015. 15 p. 223.  	 
\bibitem[De Chalain et al. ()]{b13}\label{b13} 	 		‘Leber-Gallenblase-Bauchspeicheldruese/Bauch speicheldruesen-entzuendung-Pankreatitis/ Ursachen.html 16. Classification of acute pancreatitis-2012: revision of the Atlanta classification and definitions by international consensus’.  		 			Tmb De Chalain 		,  		 			Michell Wl Berger 		,  		 			Gmb Hyperlipidemia 		.  		 \url{http://www.gesundheits-lexikon.com/}  	 	 		\textit{/ 15. Ursachen Bauchspeicheldrüsenentzündung (Pankreatitis)},  				1988. 2013. 167 p. .  	 	 (Gut) 
\bibitem[Bahiyah Abdullah,1,2 Thanikasalam Kathiresan Pillai ()]{b21}\label{b21} 	 		‘Lim HuayCheen,2 and Ray Joshua Ryan2 Severe Acute Pancreatitis in Pregnancy Case Reports in’.  		 \xref{http://dx.doi.org/10.1155/2015/239068Tangetal.Medicine}{10.1155/2015/239068Tangetal.Medicine}.  		 ID 239068.  		 \url{http://dx.doi.org/10.1155/2015/239068Tangetal.Medicine}  	 	 		\textit{Obstetrics and Gynecology}  		Bahiyah Abdullah,1,2 Thanikasalam Kathiresan Pillai (ed.)  		2018. 1  (2)  p. 7.  	 
\bibitem[Lingyu Luo Clinical characteristics of acute pancreatitis in pregnancy: experience based on 121 cases Archives of Gynecology and Obstetrics ()]{b4}\label{b4} 	 		‘Lingyu Luo Clinical characteristics of acute pancreatitis in pregnancy: experience based on 121 cases’.  	 	 		\textit{Archives of Gynecology and Obstetrics}  		2018. 297 p. .  	 
\bibitem[Vishnu Priya et al. ()]{b35}\label{b35} 	 		‘Maternal and perinatal outcome of acute pancreatitis during pregnancy: A 5 year experience at a tertiary care centre’.  		 			Kmn Vishnu Priya 		,  		 			C N Sheela 		,  		 			Shruti Banka 		,  		 			T Mahalakshmi 		.  	 	 		\textit{Int J ReprodContraceptObstet Gynecol}  		2016. 5 p. .  	 
\bibitem[Igbinosa et al. ()]{b33}\label{b33} 	 		‘Pregnancy associated pancreatitis revisited’.  		 			O Igbinosa 		,  		 			S Poddar 		,  		 			C Pitchumoni 		.  	 	 		\textit{Clin Res HepatolGastroenterol}  		2013. 37 p. .  	 
\bibitem[Tian et al. ()]{b36}\label{b36} 	 		‘Relationship between pitch value or S/ D ratio of torsion of cord and fetal outcome’.  		 			C F Tian 		,  		 			M H Kang 		,  		 			W Wu 		.  	 	 		\textit{PrenatDiagn}  		2010. 30 p. .  	 
\bibitem[Geng et al. ()]{b7}\label{b7} 	 		‘Severe acute pancreatitis during pregnancy: eleven years experience from a surgical intensive care unit’.  		 			Y Geng 		,  		 			W Li 		,  		 			L Sun 		,  		 			Z Tong 		,  		 			N Li 		,  		 			J Li 		.  		 \xref{http://dx.doi.org/10.1007/s10620-011-1809-5}{10.1007/s10620-011-1809-5}.  	 	 		\textit{Dig Dis Sci}  		2011. 56  (12)  p. .  	 
\bibitem[Wong and Ooi ()]{b40}\label{b40} 	 		‘Severe gestational hypertriglyceridemia: A practical approach for clinicians’.  		 			B Wong 		,  		 			T C Ooi 		,  		 			KeelyE 		.  	 	 		\textit{Obstet Med}  		2015. 8 p. .  	 
\bibitem[The secret of the death of Alexander the Great is revealed]{b0}\label{b0} 	 		\textit{The secret of the death of Alexander the Great is revealed},  		 \url{https://hvylya.net/news/exclusive/raskryta-tajna-smerti-aleksandra-makedonskogo.html}  		 	 
\bibitem[Avsar et al. ()]{b34}\label{b34} 	 		‘Unexpected fetal demise despite the reactive nonstress test during the conservative management of acute pancreatitis in pregnancy’.  		 			A F Avsar 		,  		 			M Yildirim 		,  		 			A Cinkaya 		.  	 	 		\textit{Int J Surg Case Rep}  		2014. 5 p. .  	 
\bibitem[Working Group IAPAPAAPGIAP/APA evidencebased guidelines for the management of acute pancreatitis Pancreatology ()]{b32}\label{b32} 	 		‘Working Group IAPAPAAPGIAP/APA evidencebased guidelines for the management of acute pancreatitis’.  	 	 		\textit{Pancreatology}  		2013. 13 p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
